Cytori Fattens Coffers: $18.5M for Adipose Stem Cell Efforts

About $18.5 million in net proceeds from a public offering by Cytori Therapeutics Inc. will go toward boosting the Celution System for processing adipose-derived regenerative cells (ADRCs), as well as clinical trials and general corporate purposes, the company said.